<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8A92553D-822E-4045-823C-9C8CCA624CD1"><gtr:id>8A92553D-822E-4045-823C-9C8CCA624CD1</gtr:id><gtr:firstName>Magnus</gtr:firstName><gtr:surname>Rattray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C41693CA-6F30-468C-96DC-E5F78269BDAD"><gtr:id>C41693CA-6F30-468C-96DC-E5F78269BDAD</gtr:id><gtr:firstName>Crispin</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Miller</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5A937F94-60FB-4497-903E-1FADE92A6401"><gtr:id>5A937F94-60FB-4497-903E-1FADE92A6401</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Exley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/053E292F-1B2D-4CCB-A9B1-5AEAC98AE73C"><gtr:id>053E292F-1B2D-4CCB-A9B1-5AEAC98AE73C</gtr:id><gtr:firstName>Caroline</gtr:firstName><gtr:surname>Dive</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B14A701D-B5D2-406C-9D53-66ADF1C6B239"><gtr:id>B14A701D-B5D2-406C-9D53-66ADF1C6B239</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Ray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C047998C-37DB-4DCE-98E1-A4BA02F0D930"><gtr:id>C047998C-37DB-4DCE-98E1-A4BA02F0D930</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>White</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F3AF47FC-52EA-49D6-8520-F63D45185E65"><gtr:id>F3AF47FC-52EA-49D6-8520-F63D45185E65</gtr:id><gtr:firstName>Cay</gtr:firstName><gtr:surname>Kielty</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FM008908%2F1"><gtr:id>8F1FE5D7-0E05-42E9-A646-483010AFE46D</gtr:id><gtr:title>Advancing therapeutics by exploiting single cell functional analysis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M008908/1</gtr:grantReference><gtr:abstractText>The human body contains trillions of cells of many different lineages and functions, yet all are descended from the same fertilised embryo. Understanding their similarities and differences (cell 'heterogeneity') is a huge barrier to the design of all therapies that need to target particular rare cells within the body. There is an increasing need to analyse the basis of how varying groups of cells arise, as well as the set of characteristics (biomarkers) that mark them out as being different. This may be due to stable changes, or dynamic changes in these cells that lead to repeatedly fluctuating cell characteristics. It is important to understand when and whether each of these possible situations applies. This requires new technical advances that can better analyse these cells to show the basis of this variation and to identify, characterise and manipulate important groups of cells that underly disease processes.
We focus on characterising a group of rare cells (called circulating tumour cells, or CTCs) that give rise to drug-resistant cancers such as certain lung cancers and lead to relapse, and specific stem cells (cells with the potential to self-renew or differentiate) that can enable the regeneration of damaged tissues such as muscle, joints, skin and blood vessels.
To achieve a 'step-advance' in our ability to design therapies that can specifically target such specific 'progenitor' cell populations, we will establish a ground-breaking Single Cell Research Centre (SCRC) at the University of Manchester. Exploiting and innovating in the very latest single cell technologies, it will comprise a common integrated pipeline from receipt of clinical samples, to identification and characterisation of single target cells within each sample, to the design of treatments that target these specific cells. In this way, it will expedite progress to cell-based and 'personalised' treatments for some of the most challenging diseases and degenerative conditions of man. 
Our vision for SCRC is that, within the first 3-5 years, the cellular 'signatures' will have been obtained and verified that will form the basis for potent new 'precision' therapies. The establishment of SCRC is thus particularly timely, given the rapidly growing numbers of people with degenerative conditions and untreatable cancers.</gtr:abstractText><gtr:technicalSummary>We will establish a Single Cell Research Centre (SCRC) to enable targeted cancer and regenerative medicine therapies. It will deliver a unified track from clinical tissue to cell selection, 'omics and imaging analysis, bioinformatics and e-Health. 
Lab 1 will handle and store clinical tissues and cells. Laser capture microscopy will enable identification and isolation of single cells from tissues. Innovative microfluidics will enable live single cell selection, delivery and imaging (with Zeiss). Labs 2 and 3 will support multi-parameter flow cytometry. Lab 2 will house an ImageStreamX flow cytometer to image, quantify and select cells in suspension; Lab 3 will house a time of Flight Mass Cytometry (cyTOF) for single cell high speed flow cytometry with targeted mass spectrometry. We will innovate in imaging cyTOF for high spatial resolution of multiple proteins in cells within clinical tissues. Lab 4 will undertake single cell genomic/transcriptomic analysis using a Fluidigm C1 and Fluidigm IFC Controller HX, building on existing platforms. The SCRC - CRUK Manchester Institute oncology lab, fully integrated in 'omics technologies and informatics, is defining circulating tumour cells. it will use NextSeq 500 and Nanostring in on-site GCLP facilities for RNA/DNA analyses of patient CTCs, to enable transition to CTC-based diagnostics. Lab 5 will innovate in imaging single cells from clinical tissues, using confocal microscopy with multiphoton laser, 4D light sheet and luminescence imaging. Fluorescence correlation spectroscopy will enable dynamic quantification of molecules in cells. Lab 6 will integrate bioinformatics with network analysis and co-varying signals, infer regulatory interactions underlying differentiation, model gene expression dynamics, and develop models of cell processes from clinical samples. All data will be integrated with our Health e-Research Centre (HeRC), part of MRC-funded Farr Institute for Health Informatics.</gtr:technicalSummary><gtr:potentialImpactText>We will establish a ground-breaking Single Cell Research Centre (SCRC) at the University of Manchester in order to deliver a step-advance in the design of therapies to target specific 'progenitor' cell populations. It will exploit and advance single cell technologies (genomics/transcriptomics, flow cytometry, proteomics, imaging and bioinformatics. It will be a fully integrated SCRC pipeline from receipt of clinical samples, to identification and genomic and phenotypic characterisation of target cells, to technology innovation and design of treatments that target specific cells. 
Our vision for SCRC is that, within the first 3-5 years, cellular 'signatures' will have been obtained and verified that will form the basis for potent precision therapies for many challenging diseases and degenerative conditions. 

Biomedical scientists 
SCRC will deliver essential insights into cell heterogeneity and the very nature of multicellularity, and thus both how tissues form and can be remodelled and how mutations can cause drug-resistant cancers. 
Realising the benefits: In Manchester, our research will be translated through Manchester Academic Health Science Centre (MAHSC) Experimental Medicine. Nationally, SCRC is a founding partner of (i) the Northern Single Cell Consortium (with Newcastle and Leeds) which will maximise added value by shared technology innovation and access to clinical material; (ii) the UK cyTOF user group which will work together to advance this new technology. SCRC is strongly linked with national CRUK collaborators and has UK Regenerative Medicine Platform hubs partnerships. We will share SCRC advances with regional colleagues in the Mercia Stem Cell Alliance (http://www.msca.ls.manchester.ac.uk/). Internationally, we will extend existing worldwide collaborations in cancer and regenerative medicine. 

Patients 
SCRC will allow characterisation of rare circulating tumour cells that give rise to drug-resistant populations, for directed early therapy to block relapse and metastasis, and the selection, expansion and characterisation of stem/progenitor cells to underpin repair and regeneration of muscle, joints, skin and vasculature. 
Realising the benefits: Within its first 3-5 years, these cellular signatures will lead to targeted cell-based precision therapies. 

Biopharma 
Single cell research is urgently needed to inform the design and delivery of cell-based biologics. This need is highlighted by the many industrial partnerships we have established for SCRC. As an example, Zeiss is committing &amp;pound;428K to SCRC in order to work together in partnership to innovate in single cell imaging, and in microfluidics of single cells, on top of ~&amp;pound;1m for our Systems Microscopy Centre. Our SCRC capabilities will also be integrated with N8 which has &amp;gt;240 industrial partners. 
Realising the benefits: University of Manchester Intellectual Property (UMIP) and the CRUK Manchester Institute's Drug Discovery Unit will support commercialisation of our single cell advances towards therapies targeting cells that give rise to drug-resistant cancers and stem cells for tissue regeneration. We will work towards a spin-out to market single cell discoveries. 

Graduates
Graduate training of future UK leaders is a priority of the University of Manchester. Our EPSRC &amp;amp; MRC Centre for Doctoral Training in Regenerative Medicine (&amp;gt;30 industrial partners) will be linked to SCRC to ensure training in single cell technologies. Other PhD programmes that will greatly benefit from SCRC include CRUK, BBSRC DTP and Wellcome Trust and BHF 4-year programmes. 
Realising the benefits: Major impact will arise by graduate training in the latest technologies to analyse and exploit cell heterogeneity. 

General Public 
Public engagement is a top University priority. .
Realising the benefits: SCRC will be a powerful platform to inform the public about our translational research, through NowGen and Faculty activities (see also Communications)</gtr:potentialImpactText><gtr:fund><gtr:end>2016-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>4916148</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>daniel davis</gtr:description><gtr:id>048519B9-5058-4978-9775-02ADC3CDEE06</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>he is using single cell sequencing approaches.</gtr:partnerContribution><gtr:piContribution>daniel is working on The nanoscale organisation of na&amp;iuml;ve and regulatory T cell surfaces in juvenile idiopathic arthritis patients with wellcome support</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>hannah durrington</gtr:description><gtr:id>AD8AB30B-BC12-44E6-984C-046D3C63CB8C</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>she is using FACS and single cell genomics</gtr:partnerContribution><gtr:piContribution>Hannah is working on Applying single cell technology to Steroid Resistant Asthma: identifying the role of circadian mechanisms in Th17 cells. with wellcome support</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>sebastian viatte</gtr:description><gtr:id>A15155D7-E07A-44D5-9C42-12F5B75A5E9D</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>he is using the kit, with funding from wellcome</gtr:partnerContribution><gtr:piContribution>Seb is working on Monocyte heterogeneity in health and inflammatory disease with wellcome support</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>andrew mc donald</gtr:description><gtr:id>B6EC34CC-B1A3-4DA5-AE28-9A1D157ECA84</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>he is using the new kit.</gtr:partnerContribution><gtr:piContribution>andrew is developing high resolution analysis of lung immune cells. in human asthma.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>john blaikley</gtr:description><gtr:id>06D8D284-AEBD-4860-82A0-C165C76AB3E2</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>he is using the kit, with wellcome and MRC salary support.</gtr:partnerContribution><gtr:piContribution>John is working on Does single cell biological noise conceal circadian timing information? with MRC and wellcome support</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>elaine bignell</gtr:description><gtr:id>507CEB5E-CC29-4C36-96D7-AEDBDAB83F8C</gtr:id><gtr:impact>none yet</gtr:impact><gtr:partnerContribution>she is using the kit with wellcome funding the project.</gtr:partnerContribution><gtr:piContribution>elaine is working on Antifungal potency of the airway epithelium in health and disease: a single cell approach with wellcome support</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>programme grant</gtr:description><gtr:end>2022-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D1913531-74C7-4180-BE77-4B68487241A7</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>269390</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>clinical research fellowship</gtr:description><gtr:end>2019-07-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:id>7E6673B5-55C5-4CE3-8DE2-D61186E6B16F</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR/BRC</gtr:department><gtr:description>NIHR Biomedical research centre</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:fundingRef>Manchester BRC 2017-2022</gtr:fundingRef><gtr:id>020084A8-9F34-410E-A757-D3281C32150C</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>844160</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>research grant</gtr:description><gtr:end>2020-02-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:id>1DE49412-FFEF-4D1F-8689-905FF9244CDB</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>675328</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2020-02-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:fundingRef>MR/P011853/1</gtr:fundingRef><gtr:id>FBA7060D-AA49-4991-AC1F-9121A6A761F4</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>The primary focus of computational (including use of the MRC fundedcomputation and storage hardware) and bioinformatics (MRC funded Post Doc) aspects of this grant has been the development of novel analysis pipelines that reduce NGS based error and make single cell analysis more reliable. As a first step in this process we have repurposed techniques from transcript assembly to exploit the redundancy that result from sequencing multiple PCR products from each initial starting DNA fragment. This allows us to identify and correct both PCR and imaging errors in Illumina deep sequencing data. 
Our algorithm reduces background noise in the normal control samples and eliminates false positives from the tumour samples. Together these lead to significant improvement in mutation calling accuracy. The code is highly parallelised and makes use of a MapReduce framework to run efficiently on HPC hardware, such as that provided through the SCRC. The first manuscript from this research is in final stages of drafting.</gtr:description><gtr:id>D0F9C101-D4FA-4661-B2FA-D11FFF606CB0</gtr:id><gtr:impact>We intend to extend these approaches to allow us to align and assemble data from all the CTCs from a patient simultaneously, alongside patient matched normal controls. This exploits the evolutionary hierarchy resulting from all cells in the dataset being ultimately derived from the same ancestor cell. In this way, the algorithm can, for each CTC, 'borrow' information from the other CTCs in the set, improving the overall signal to noise ratio. We expect this to improve mutation-calling accuracy and to be substantially faster than other techniques. When used in a clinical setting, reducing processing time is particularly beneficial.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>algorithm for single cell genomics</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11E36A9B-19AE-4384-933C-A51D50E6F697"><gtr:id>11E36A9B-19AE-4384-933C-A51D50E6F697</gtr:id><gtr:title>MicroRNA evolution, expression, and function during short germband development in Tribolium castaneum.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a23ecc0365a4461d94ff53a59f4ed350"><gtr:id>a23ecc0365a4461d94ff53a59f4ed350</gtr:id><gtr:otherNames>Ninova M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BB15B4A8-0093-4D74-96D9-66007E52F85F"><gtr:id>BB15B4A8-0093-4D74-96D9-66007E52F85F</gtr:id><gtr:title>Signal transduction controls heterogeneous NF-?B dynamics and target gene expression through cytokine-specific refractory states.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dba0d2441f6590a38f374dcb1bc49357"><gtr:id>dba0d2441f6590a38f374dcb1bc49357</gtr:id><gtr:otherNames>Adamson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E5E1D6E-77A5-40AC-A191-B2AB8B03756B"><gtr:id>5E5E1D6E-77A5-40AC-A191-B2AB8B03756B</gtr:id><gtr:title>Stochasticity in the miR-9/Hes1 oscillatory network can account for clonal heterogeneity in the timing of differentiation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c09beeeb9d096d06e11f38b0c9d5294"><gtr:id>8c09beeeb9d096d06e11f38b0c9d5294</gtr:id><gtr:otherNames>Phillips NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/95E721ED-320A-4893-896C-F0A5F2B928D4"><gtr:id>95E721ED-320A-4893-896C-F0A5F2B928D4</gtr:id><gtr:title>The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8a3b91614947e6fb9c73d10d48dc7fb6"><gtr:id>8a3b91614947e6fb9c73d10d48dc7fb6</gtr:id><gtr:otherNames>Mohamed TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8134CC98-3415-49A3-A6CC-6512F33A0BD9"><gtr:id>8134CC98-3415-49A3-A6CC-6512F33A0BD9</gtr:id><gtr:title>Spatially coordinated dynamic gene transcription in living pituitary tissue.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e785ebe1caadb418083bec7839085582"><gtr:id>e785ebe1caadb418083bec7839085582</gtr:id><gtr:otherNames>Featherstone K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E71FC1D6-612F-4B2A-ABC1-1A7DCC473D4A"><gtr:id>E71FC1D6-612F-4B2A-ABC1-1A7DCC473D4A</gtr:id><gtr:title>An integrative transcriptomic atlas of organogenesis in human embryos.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9a9eddf48c28defea74e9aa5d5a375ae"><gtr:id>9a9eddf48c28defea74e9aa5d5a375ae</gtr:id><gtr:otherNames>Gerrard DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11B4BC43-4668-420B-AF27-A0828D9D4989"><gtr:id>11B4BC43-4668-420B-AF27-A0828D9D4989</gtr:id><gtr:title>Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/928918b304e09bf8e9e6cdc356da3139"><gtr:id>928918b304e09bf8e9e6cdc356da3139</gtr:id><gtr:otherNames>Garcia E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F41797C-89BC-4694-A999-B4AB205BB256"><gtr:id>3F41797C-89BC-4694-A999-B4AB205BB256</gtr:id><gtr:title>Visualizing and Quantifying Intracellular Behavior and Abundance of the Core Circadian Clock Protein PERIOD2.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f20c045a0b90c43fb878f36974034ddb"><gtr:id>f20c045a0b90c43fb878f36974034ddb</gtr:id><gtr:otherNames>Smyllie NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3C819FA-80D0-4163-8D97-DDECF1D95EA2"><gtr:id>B3C819FA-80D0-4163-8D97-DDECF1D95EA2</gtr:id><gtr:title>Genome-wide binding studies reveal DNA binding specificity mechanisms and functional interplay amongst Forkhead transcription factors.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7771ec39b9bd63d704f50fabca5f24ae"><gtr:id>7771ec39b9bd63d704f50fabca5f24ae</gtr:id><gtr:otherNames>Chen X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CC57F16B-634B-4204-BD9F-62055ED309E3"><gtr:id>CC57F16B-634B-4204-BD9F-62055ED309E3</gtr:id><gtr:title>PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55f6c6d440adbbc77668a052f9c0d839"><gtr:id>55f6c6d440adbbc77668a052f9c0d839</gtr:id><gtr:otherNames>Martin K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FFDB8618-2BDF-4D8A-85D9-E10A4ED93765"><gtr:id>FFDB8618-2BDF-4D8A-85D9-E10A4ED93765</gtr:id><gtr:title>Catabolic cytokines disrupt the circadian clock and the expression of clock-controlled genes in cartilage via an NF?B-dependent pathway.</gtr:title><gtr:parentPublicationTitle>Osteoarthritis and cartilage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6529a24cc5e31210c44d4493c3f85ab5"><gtr:id>6529a24cc5e31210c44d4493c3f85ab5</gtr:id><gtr:otherNames>Guo B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1063-4584</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BB2ACFA0-60A8-4DC7-890C-D9165309474B"><gtr:id>BB2ACFA0-60A8-4DC7-890C-D9165309474B</gtr:id><gtr:title>Adiponectin induces A20 expression in adipose tissue to confer metabolic benefit.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7173cc9ba6ca38770a1dac7b33f92e5"><gtr:id>b7173cc9ba6ca38770a1dac7b33f92e5</gtr:id><gtr:otherNames>Hand LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3BFABA2-FF80-4AD4-8D71-3EF686F3035C"><gtr:id>C3BFABA2-FF80-4AD4-8D71-3EF686F3035C</gtr:id><gtr:title>Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cells.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/726b00d39a70e3a6655fbb015c0e64cb"><gtr:id>726b00d39a70e3a6655fbb015c0e64cb</gtr:id><gtr:otherNames>Grundy S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DBEEA1E4-82D6-4FF3-8838-528C13BF615C"><gtr:id>DBEEA1E4-82D6-4FF3-8838-528C13BF615C</gtr:id><gtr:title>Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b8e11abf417df64c2619312c232c8bf"><gtr:id>2b8e11abf417df64c2619312c232c8bf</gtr:id><gtr:otherNames>Matthews LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1C1DA095-E492-4872-B82C-4518928E4606"><gtr:id>1C1DA095-E492-4872-B82C-4518928E4606</gtr:id><gtr:title>eIF2? is critical for eIF5-mediated GDP-dissociation inhibitor activity and translational control.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bccad523c01d0c2d6c4aad8d2288856c"><gtr:id>bccad523c01d0c2d6c4aad8d2288856c</gtr:id><gtr:otherNames>Jennings MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/158D44EE-FA9A-4DE8-9A1A-56EF2EFBA18D"><gtr:id>158D44EE-FA9A-4DE8-9A1A-56EF2EFBA18D</gtr:id><gtr:title>Inflammasome-dependent IL-1? release depends upon membrane permeabilisation.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ebade41247cd450d29273fec33bb39f2"><gtr:id>ebade41247cd450d29273fec33bb39f2</gtr:id><gtr:otherNames>Mart?n-S?nchez F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B2A9303-83C5-4319-8043-3A501DC13980"><gtr:id>2B2A9303-83C5-4319-8043-3A501DC13980</gtr:id><gtr:title>p63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93f6969913a9efededebbd3b6e5c1610"><gtr:id>93f6969913a9efededebbd3b6e5c1610</gtr:id><gtr:otherNames>Awais R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F1CE11A-0834-4F14-91D0-EC086A659C21"><gtr:id>0F1CE11A-0834-4F14-91D0-EC086A659C21</gtr:id><gtr:title>Regulation of the BMP Signaling-Responsive Transcriptional Network in the Drosophila Embryo.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c7c2c3d56242d3a2f5f0bde3399a2142"><gtr:id>c7c2c3d56242d3a2f5f0bde3399a2142</gtr:id><gtr:otherNames>Deignan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/202F1B8B-F2C5-4E2B-AC7B-5A67ADDEB007"><gtr:id>202F1B8B-F2C5-4E2B-AC7B-5A67ADDEB007</gtr:id><gtr:title>Dynamic NF-?B and E2F interactions control the priority and timing of inflammatory signalling and cell proliferation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e0e38be90a63e0284f712d735e9d2194"><gtr:id>e0e38be90a63e0284f712d735e9d2194</gtr:id><gtr:otherNames>Ankers JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/28D52421-BF7B-44DE-B027-F80263589FC3"><gtr:id>28D52421-BF7B-44DE-B027-F80263589FC3</gtr:id><gtr:title>Understanding the dynamics of Toll-like Receptor 5 response to flagellin and its regulation by estradiol.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/03e3f281f991842a94363c7902ec5bee"><gtr:id>03e3f281f991842a94363c7902ec5bee</gtr:id><gtr:otherNames>Caballero I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/781032AD-D5ED-471E-AC75-DA63B78173E3"><gtr:id>781032AD-D5ED-471E-AC75-DA63B78173E3</gtr:id><gtr:title>Role of Estrogen Response Element in the Human Prolactin Gene: Transcriptional Response and Timing.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d2fe6cce9a17f42db4c37fae2e94793f"><gtr:id>d2fe6cce9a17f42db4c37fae2e94793f</gtr:id><gtr:otherNames>McNamara AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E5DBC40-34B3-4D5A-8757-16201B72294C"><gtr:id>3E5DBC40-34B3-4D5A-8757-16201B72294C</gtr:id><gtr:title>Investigating IL-1? Secretion Using Real-Time Single-Cell Imaging.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a7d5b1909d73d7e81a984b50191dc9b3"><gtr:id>a7d5b1909d73d7e81a984b50191dc9b3</gtr:id><gtr:otherNames>Diamond C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23FC7B7D-800D-4845-A782-AA7AE9889046"><gtr:id>23FC7B7D-800D-4845-A782-AA7AE9889046</gtr:id><gtr:title>The chondrocyte clock gene Bmal1 controls cartilage homeostasis and integrity.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d616f104fe92db3b61f253a25f11749"><gtr:id>4d616f104fe92db3b61f253a25f11749</gtr:id><gtr:otherNames>Dudek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5DDD9A55-CD46-41C9-BD0F-5A75A33FD613"><gtr:id>5DDD9A55-CD46-41C9-BD0F-5A75A33FD613</gtr:id><gtr:title>An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eaaa6ee8abee6eb45a1d81a831350d86"><gtr:id>eaaa6ee8abee6eb45a1d81a831350d86</gtr:id><gtr:otherNames>Rutkowski D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4CD6BB3-023F-41E4-9673-2A1B103F6CEE"><gtr:id>C4CD6BB3-023F-41E4-9673-2A1B103F6CEE</gtr:id><gtr:title>Widespread Impact of Chromosomal Inversions on Gene Expression Uncovers Robustness via Phenotypic Buffering.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/60a2b0607dc3cc999d2f2568bb4f31ee"><gtr:id>60a2b0607dc3cc999d2f2568bb4f31ee</gtr:id><gtr:otherNames>Naseeb S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D2476283-4E42-4B06-8B1A-3516C31088E4"><gtr:id>D2476283-4E42-4B06-8B1A-3516C31088E4</gtr:id><gtr:title>The intervertebral disc contains intrinsic circadian clocks that are regulated by age and cytokines and linked to degeneration.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d616f104fe92db3b61f253a25f11749"><gtr:id>4d616f104fe92db3b61f253a25f11749</gtr:id><gtr:otherNames>Dudek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M008908/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>